NeuroNYC presents Biohybrid BCIs with Science Corporation

​NeuroNYC is pleased to welcome leaders from Science Corporation for a presentation and discussion focused on biohybrid neural interface technology.

​Date: Wednesday, November 4th
Time: 5:00-7:00 p.m.
Agenda:

• ​5:00-5:45: Arrival & Networking

• ​5:45-6:00: Opening Remarks
  NeuroNYC's Margot Hanley welcomes guests and shares news

• ​6:00-6:30: Towards Dopaminergic Biohybrid Implants
  Science Corporation Co-Founder and Chief Scientific Officer Alan Mardinly and Medical Director for BCI Murat Günel share an inside look at their research and the development of a biohybrid neural interface

• ​6:30-7:00: Moderated Q&A
  Neurotech Futures' Naveen Rao will lead a group discussion
  
  Reception to follow at a nearby location.
  Note: This event is closed press/Chatham House rules.